Cargando…
Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
Dysfunction of macro- and microvessels is a major cause of morbidity and mortality in patients with cardio-renovascular diseases such as atherosclerosis, hypertension, and diabetes. Renal failure and impairment of renal function due to vasoconstriction of the glomerular arteriole in diabetic nephrop...
Autores principales: | Sen, Utpal, Tyagi, Suresh C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895301/ https://www.ncbi.nlm.nih.gov/pubmed/20613990 http://dx.doi.org/10.1155/2010/806538 |
Ejemplares similares
-
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
por: Mishra, Paras K, et al.
Publicado: (2010) -
PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice
por: Rodriguez, Walter E., et al.
Publicado: (2008) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012) -
PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs
por: Luan, Jinwen, et al.
Publicado: (2023) -
Defective Homocysteine Metabolism: Potential Implications for Skeletal Muscle Malfunction
por: Veeranki, Sudhakar, et al.
Publicado: (2013)